Skip to main content
logo
Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,070.00
+1,065.00 (26.59%)
Sep 1, 2026, 3:30 PM KST

Vaxcell-Bio Therapeutics Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
117,915239,819516,197519,865660,6782,517,196
Market Cap Growth
-43.29%-53.54%-0.71%-21.31%-73.75%-
Enterprise Value
79,870192,973504,030497,951646,3232,482,604
Last Close Price
5070.0010430.0022450.0026694.2033924.69130774.23

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
-126.2937614.61---
PB Ratio
-3.336.1822.2921.9672.61
P/TBV Ratio
-3.576.2022.5122.0772.75

EV Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
EV/Sales Ratio
-101.6236727.98---

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
0.030.030.000.010.010.01
Asset Turnover
0.020.020---
Inventory Turnover
9.199.19----
Quick Ratio
13.4513.4554.7867.1070.5131.98
Current Ratio
13.8713.8755.4368.0671.8832.29
Return on Equity (ROE)
-13.66%-13.66%-19.24%-25.56%-14.71%-18.22%
Return on Assets (ROA)
-11.64%-11.64%-13.18%-18.52%-11.05%-11.68%
Return on Invested Capital (ROIC)
-11.92%-11.92%-13.41%-19.11%-11.30%-11.94%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Aug '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
--4.43%-1.99%-1.31%-0.72%-0.16%
FCF Yield
-10.88%-5.35%-1.86%-1.20%-1.03%-0.13%
Buyback Yield / Dilution
-17.03%-17.03%-28.80%-0.68%-122.02%-55.35%